Hepatitis D, Chronic Clinical Trial
Official title:
A Multicenter Randomised Study Comparing the Antiviral Efficacy of Pegylated Interferon-alfa-2a Plus Placebo vs. Pegylated Interferon-alfa-2a Plus Tenofovir for the Treatment of Chronic Delta Hepatitis
This randomized, single blind study will compare the antiviral effect of Pegasys (pegylated interferon alfa-2a) plus placebo versus Pegasys plus tenofovir in patients with chronic hepatitis D. Patients will be randomized to receive 96 weeks of therapy with Pegasys (180 micrograms sc weekly) plus either placebo (orally daily) or tenofovir (245mg orally daily). Anticipated time on study treatment is 2+ years, target sample size is <50.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05461170 -
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
|
Phase 2 | |
Active, not recruiting |
NCT04535544 -
A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus
|
Phase 2 | |
Completed |
NCT02732639 -
A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
|
Phase 3 | |
Completed |
NCT02731131 -
A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
|
Phase 2 | |
Completed |
NCT02765802 -
A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
|
Phase 2 | |
Active, not recruiting |
NCT05229991 -
Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection
|
Phase 3 | |
Terminated |
NCT01861444 -
An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
|
N/A | |
Active, not recruiting |
NCT03105310 -
Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
|
Phase 2 | |
Recruiting |
NCT04166266 -
Observatory of Efficacy and Safety of Bulevirtide in Patients With Chronic HBV/HDV Co-infection
|
||
Completed |
NCT00686790 -
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
|
Phase 3 | |
Completed |
NCT02876419 -
A Long Term Follow-up Study of Patients From the REP 301 Protocol
|